Skip to main content

Table 1 Patient characteristics

From: Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

  

5-FU, Mitomycin C

Gemcitabine, Cisplatin

  

patients

%

patients

%

All patients

 

35

 

58

 

Age

Median (Range)

63 (37 - 75)

63 (35 - 76)

Gender

Male

23

66

36

62

 

Female

12

34

22

38

Surgery

No resection

26

74

41

71

 

resection

9

26

15

29

Tumour location

Head

25

71

40

69

 

Head/Body

3

9

5

9

 

Body

5

14

9

16

 

Body and tail

1

3

3

5

 

tail

-

-

1

2

cT 1997

1

1

3

2

3

 

2

8

23

8

14

 

3

8

23

16

28

 

4

18

51

32

55

cN 1997

0

15

43

27

47

 

1

20

57

31

53

UICC 1997

I

4

11

7

12

 

II

3

9

7

12

 

III

9

26

12

20

 

IVa

17

49

31

53

 

IVb

2

6

1

1

Grading

1

3

9

3

5

 

2

15

43

28

48

 

3

5

14

16

28

 

4

0

-

0

-

  1. Abbreviations: R0 = clear resection, R1 = positive margin, RX = resection margin uncertain.